Formulation Development, Physicochemical Characterization and In Vitro-In Vivo Drug Release of Vaginal Films
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14740%2F16%3A00093893" target="_blank" >RIV/00216224:14740/16:00093893 - isvavai.cz</a>
Výsledek na webu
<a href="http://www.eurekaselect.com/136942/article" target="_blank" >http://www.eurekaselect.com/136942/article</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/1570162X14666151113123040" target="_blank" >10.2174/1570162X14666151113123040</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Formulation Development, Physicochemical Characterization and In Vitro-In Vivo Drug Release of Vaginal Films
Popis výsledku v původním jazyce
Purpose: The purpose of this study was formulation and optimization of vaginal film formulation containing abacavir (ABC), a potent nucleoside reverse transcriptase inhibitor. Methods: Vaginal films were prepared by solvent evaporation method using hydroxypropyl methylcellulose (HPMC) blended with polyvinyl pyrrolidone (PVP). Various physicochemical parameters of the prepared films such as drug content, thickness, tensile strength, percentage elongation at break, drug polymer interaction, swelling capacity, folding endurance, bio-adhesion, pH, and moisture content were evaluated with morphological studies. In vitro release study and in vivo release study were also performed. Results: Films exhibited favorable physicochemical properties. The in vitro study showed that HPMC-PVP combination can control the release of abacavir through vaginal films with higher amount of PVP in the formulation resulting in an enhanced drug release rate.
Název v anglickém jazyce
Formulation Development, Physicochemical Characterization and In Vitro-In Vivo Drug Release of Vaginal Films
Popis výsledku anglicky
Purpose: The purpose of this study was formulation and optimization of vaginal film formulation containing abacavir (ABC), a potent nucleoside reverse transcriptase inhibitor. Methods: Vaginal films were prepared by solvent evaporation method using hydroxypropyl methylcellulose (HPMC) blended with polyvinyl pyrrolidone (PVP). Various physicochemical parameters of the prepared films such as drug content, thickness, tensile strength, percentage elongation at break, drug polymer interaction, swelling capacity, folding endurance, bio-adhesion, pH, and moisture content were evaluated with morphological studies. In vitro release study and in vivo release study were also performed. Results: Films exhibited favorable physicochemical properties. The in vitro study showed that HPMC-PVP combination can control the release of abacavir through vaginal films with higher amount of PVP in the formulation resulting in an enhanced drug release rate.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
EC - Imunologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
CURRENT HIV RESEARCH
ISSN
1570-162X
e-ISSN
—
Svazek periodika
14
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
AE - Spojené arabské emiráty
Počet stran výsledku
12
Strana od-do
295-306
Kód UT WoS článku
000378058100001
EID výsledku v databázi Scopus
—